PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

BOSTON --(BUSINESS WIRE)--Dec. 8, 2025-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of